World Pharma News / Search results for amgen

1
Vote

Japan's Takeda Pharma unaffected by planned Amgen unit acquisition - S&P - Forbes.com

Posted by G00gle 289 days ago (http://www.forbes.com)
Category: Corporate | Tags: takeda amgen

Standard & Poor's Ratings Services said its ratings on Takeda Pharmaceutical Co Ltd would remain unaffected by the company's plan to buy Amgen KK, read more »
Discuss Add this link to... Bury

1
Vote

Amgen Compares Roche to 'Snake-Oil Salesman'

Posted by G00gle 274 days ago (http://blogs.wsj.com)
Category: Blogs | Tags: amgen roche

Nothing spices up a patent dispute like a little name-calling. So we were eager to read Amgen's filing today in its patent case against Roche, after we got a juicy tip from Dow Jones Newswires' Tho read more »
Discuss Add this link to... Bury

1
Vote

Pharmalot » Amgen Adds New Warnings To Anemia Meds

Posted by G00gle 257 days ago (http://www.pharmalot.com)
Category: Product | Tags: amgen aranesp epogen procrit

Specifically, the warning says the drugs, which are used to treat anemia in patients with kidney failure and on chemotherapy, increased death and accelerated tumor growth in patients with early stage read more »
Discuss Add this link to... Bury

1
Vote

Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)

Posted by worldpharmanews 255 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: amgen aranesp epogen

Amgen Inc. (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved updated safety information, including an updated boxed warning in the labeling information for the cl read more »
Discuss Add this link to... Bury

2
Vote

Amgen, JNJ Get Somewhat Mixed Message From FDA Panel - MSNBC.com

Posted by G00gle 251 days ago (http://www.cnbc.com)
Category: Blogs | Tags: amgen johnson & johnson fda

Amgen, the world's biggest biotech company in terms of sales and Dow component Johnson & Johnson avoided a worst-case scenario this afternoon. A Food and Drug Administration advisory committee voted read more »
Discuss Add this link to... Bury

1
Vote

Amgen's First Quarter 2008 Adjusted Earnings Per Share Increased 4 percent to $1.12

Posted by worldpharmanews 206 days ago (http://www.worldpharmanews.com)
Category: Financial | Tags: amgen

Amgen (NASDAQ:AMGN) reported adjusted earnings per share (EPS), excluding stock option expense and certain other expenses, of $1.12 for the first quarter of 2008, an increase of 4 percent compared to read more »
Discuss Add this link to... Bury

1
Vote

Amgen Posts Medical Education and Foundation Grants and Donations

Posted by worldpharmanews 177 days ago (http://www.worldpharmanews.com)
Category: Corporate | Tags: amgen

Amgen (NASDAQ: AMGN) posted to the company's Web site grants and donations made by the Amgen Medical Education department (AmgenMED) and the Amgen Foundation. The posting is the latest element of Cl read more »
Discuss Add this link to... Bury

1
Vote

Romiplostim Data Show Potential Long-Term Efficacy and Safety

Posted by worldpharmanews 156 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: amgen romiplostim

Amgen Inc. (NASDAQ: AMGN) announced updated results from the ongoing, open-label extension study on the long-term safety and efficacy of romiplostim in adult patients with chronic immune thrombocytop read more »
Discuss Add this link to... Bury